跳至主要内容
临床试验/NL-OMON36233
NL-OMON36233已完成4 期

Pilot study: performance of the Progensa PCA3 test in post-oxytocin urine specimens - Pilot: Efficacy of Progensa PCA3 test in post-oxytocin urine

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy male subject
  • >= 18 years old

排除标准

  • history of prostate cancer
  • use of medication known to affect PSA level (eg. finasteride, dutasteride)
  • Symptoms of urinary tract infection

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验

进行中(未招募)
1 期
Pilot study: performance of the Progensa PCA3 test in post-oxytocin urine specimens - Pilot: Progensa PCA3 test in post-oxytocin urineHealthy volunteer trial: intended indication for product is to mobilize prostate cells in urethra for PCA3 test.MedDRA version: 12.1Level: PTClassification code 10033329Term: Oxytocin
EUCTR2010-024649-61-NLRadboud University Nijmegen Medical Centre10
进行中(未招募)
1 期
Diagnostic performance of [18F]CTT1057 PET in BCRProstate cancer with rising PSA levels [biochemical recurrence (BCR)]MedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2020-003959-16-ESovartis Farmacéutica S.A.190
进行中(未招募)
1 期
Diagnostic performance of [18F]CTT1057 PET in BCRProstate cancer with rising PSA levels [biochemical recurrence (BCR)]MedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2020-003959-16-FRovartis Pharma AG190
已完成
不适用
euprolide acetate 3 month depot medicine use in advance prostate cancer
CTRI/2021/07/034710Bharat Serums and Vaccines ltd8
进行中(未招募)
1 期
First study to test the validity of the treatment of the disease called idiopathic pulmonary fibrosis, which causes inflammation and fibrosis (scarring) of the lung tissue, with a drug called cotrimoxazole.Ambulatory patients, men and women, with well-established diagnosis of idiopathic pulmonary fibrosis.MedDRA version: 14.1Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2012-005409-38-ESFundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)56